Bioinformatics to Identify Optimal Solid Tumor Targets and Improve Antigen Selection
Time: 3:00 pm
day: Day One
Details:
- Discuss what is the CD19 equivalent in solid tumors?
- Review the clinical potential of HER2, MAC3, MAC4, Mage3, Mage4, and more
- Best-in-class bioinformatics platforms to identify safe tumor targets
